GTF Statement on US Court Case against Monsanto
The Glyphosate Task Force (GTF) takes note of the decision of the Superior Court of California in the case which claimed Monsanto’s product Roundup caused cancer in a former groundskeeper who used the product. Glyphosate is the active ingredient in Roundup.
We sympathise with the plaintiff and his circumstances. The plaintiff had a very compelling and emotional story, but the verdict by the U.S. jury does not change the science.
More than 800 scientific studies, the European Food Safety Authority (EFSA), the European Chemicals Agency (ECHA), the German Federal Institute for Risk Assessment (BfR), the U.S. EPA, and every regulatory agency in the world has concluded that glyphosate is safe for its intended use.
Moreover, the U.S Agricultural Health Study (AHS) – the largest and most comprehensive study ever conducted on the use of formulated pesticide products in the world – reviewed the health of thousands of agricultural workers, farmers and their families since the 1990s and found no link between glyphosate and cancer.
In December 2017, the EU re-authorised the use of glyphosate for another five years following the most robust scientific and regulatory assessment it had ever undertaken. That process included a review of all relevant claims as to the carcinogenicity of glyphosate, including that of IARC whose findings played a substantial role in the U.S. court case.
The GTF reaffirms its confidence in and commitment to overwhelming scientific evidence and awaits further developments in the U.S. in this regard.
Last update: 14 August 2018